UK-based DefiniGEN has developed iPSC-derived cell lines that can replace primary human hepatocytes for toxicity testing and accelerate the development of novel liver-targeted therapeutics. Drugmakers ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...

The global in vitro toxicity testing market is expected to expand at a compound annual growth rate of around 10% during the forecast period, reflecting the increasing need for safer, faster, and more ...

The Business Research Company’s In-Vitro Diagnostics Instruments Global Market Report 2026 - Market Size, Trends, And Global Forecast 2026-2035 The Business Research Company’s In-Vitro Diagnostics ...